Melanoma Growth Stimulatory Activity in Primary Malignant Melanoma: Prognostic Significance

[1]  A. Bosserhoff,et al.  Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens. , 2000, Human pathology.

[2]  Wei Yang,et al.  MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression , 2000, Oncogene.

[3]  M. Burdick,et al.  The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma , 2000, Journal of leukocyte biology.

[4]  M. Burdick,et al.  Enhanced tumor‐forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth‐regulated cytokine β and γ proteins , 1997 .

[5]  E. Miller,et al.  A synthetic peptide inhibitor for alpha-chemokines inhibits the growth of melanoma cell lines. , 1997, The Journal of clinical investigation.

[6]  R. Parwaresch,et al.  Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions. , 1995, The American journal of pathology.

[7]  O. Larsson,et al.  Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties , 1995, Melanoma research.

[8]  P. Grammatico,et al.  Involvement of the 4q21 region in human malignant melanomas: Cytogenetic and immunocytochemical characterization of three primary cell cultures , 1995, World Journal of Surgery.

[9]  G. Auer,et al.  Morphometric, DNA, and Proliferating Cell Nuclear Antigen Measurements in Benign Melanocytic Lesions and Cutaneous Malignant Melanoma , 1994, The American Journal of dermatopathology.

[10]  R. Kerbel,et al.  Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. , 1994, The American journal of pathology.

[11]  T. Saida,et al.  Growth dynamics of acquired melanocytic nevi. Higher reactivity of proliferating cell nuclear antigen in junctional and compound nevi than intradermal nevi. , 1994, Journal of the American Academy of Dermatology.

[12]  D. Ruiter,et al.  Molecular markers of melanocytic tumor progression. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[13]  C. Garbe,et al.  Cytokines in human melanoma cells: synthesis, autocrine stimulation and regulatory functions—an overview , 1993, Melanoma research.

[14]  L. Nanney,et al.  Localization of MGSA/GRO protein in cutaneous lesions , 1993, Journal of cutaneous pathology.

[15]  M. G. Fleming,et al.  Immunohistochemical Localization of Cytokines in Nevi , 1992, The American Journal of dermatopathology.

[16]  M C Mihm,et al.  Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[17]  A. Richmond,et al.  The pathogenic role of growth factors in melanoma. , 1991, Seminars in dermatology.

[18]  R. Derynck,et al.  Effects of MGSA/GRO alpha on melanocyte transformation. , 1991, Oncogene.

[19]  R. Fine,et al.  Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes , 1990, Journal of cellular biochemistry.

[20]  P. Griffin,et al.  Recombinant expression, biochemical characterization, and biological activities of the human MGSA/gro protein. , 1990, Biochemistry.

[21]  R. Hofmann-Wellenhof,et al.  Vascular architecture of melanocytic skin tumors. A quantitative immunohistochemical study using automated image analysis. , 1989, Pathology, research and practice.

[22]  D. Elder,et al.  Tumor progression in the human melanocytic system. , 1989, Anticancer research.

[23]  R. Derynck,et al.  Expression and secretion of gro/MGSA by stimulated human endothelial cells. , 1989, The EMBO journal.

[24]  A. Richmond,et al.  Melanoma growth stimulatory activity: Isolation from human melanoma tumors and characterization of tissue distribution , 1988, Journal of cellular biochemistry.

[25]  W. Clark,et al.  Biology of tumor progression in human melanocytes. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[26]  A. Richmond,et al.  Purification of melanoma growth stimulatory activity , 1986, Journal of cellular physiology.

[27]  R. Fine,et al.  Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. , 1986, The Journal of investigative dermatology.

[28]  R. Strieter,et al.  Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. , 1997, International journal of cancer.

[29]  T. Dooley.  Recent advances in cutaneous melanoma oncogenesis research. , 1994, Oncology research.

[30]  Dooley Tp.  Recent advances in cutaneous melanoma oncogenesis research. , 1994 .